[Synthesis and cytotoxicity of allobetulin derivatives]. 2014

O B Kazakova, and I E Smirnova, and E F Khusnutdinova, and O S Zhukova, and L V Fetisova, and G N Apryshko, and N I Medvedeva, and E Iu Iamansarov, and I P Baĭkova, and Thanh Tra Nguen, and Do Thi H Thu

The synthesis and screening of antitumor activity in vitro (cytotoxicity) of various oxygen, nitrogen, sulfur and platinum-containing derivatives of allobetulin, including different arrangements of the double bonds in the A and B rings, penta- and hexacyclic ring A, 21-acetyl-20,28-epoxy-18α,19βH-ursane-isomeric cycle E, was carry out. (3R,5R)-19β,28-Epoxy-4,5-seco-18α-olean-3(5)-ozonide and 2,3-indolo-21β-acetyl-20β,28-epoxy-18α, H-19β-ursane showed significant cytotoxic activity against melanoma MeWo and Leukemia SR cells, appropriately. (3S,5S)-Diastereomer of the first compound showed no cytotoxicity.

UI MeSH Term Description Entries
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014315 Triterpenes A class of terpenes (the general formula C30H48) formed by the condensation of six isoprene units, equivalent to three terpene units. Triterpene,Triterpenoid,Triterpenoids
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular
D056945 Hep G2 Cells A human liver tumor cell line used to study a variety of liver-specific metabolic functions. Cell Line, Hep G2,Cell Line, Hepatoblastoma G2,Hep G2 Cell Line,HepG2 Cells,Hepatoblastoma G2 Cell Line,Cell, Hep G2,Cell, HepG2,Cells, Hep G2,Cells, HepG2,Hep G2 Cell,HepG2 Cell

Related Publications

O B Kazakova, and I E Smirnova, and E F Khusnutdinova, and O S Zhukova, and L V Fetisova, and G N Apryshko, and N I Medvedeva, and E Iu Iamansarov, and I P Baĭkova, and Thanh Tra Nguen, and Do Thi H Thu
March 2011, Molecules (Basel, Switzerland),
O B Kazakova, and I E Smirnova, and E F Khusnutdinova, and O S Zhukova, and L V Fetisova, and G N Apryshko, and N I Medvedeva, and E Iu Iamansarov, and I P Baĭkova, and Thanh Tra Nguen, and Do Thi H Thu
January 2010, Bioorganicheskaia khimiia,
O B Kazakova, and I E Smirnova, and E F Khusnutdinova, and O S Zhukova, and L V Fetisova, and G N Apryshko, and N I Medvedeva, and E Iu Iamansarov, and I P Baĭkova, and Thanh Tra Nguen, and Do Thi H Thu
July 2015, Bioorganic & medicinal chemistry,
O B Kazakova, and I E Smirnova, and E F Khusnutdinova, and O S Zhukova, and L V Fetisova, and G N Apryshko, and N I Medvedeva, and E Iu Iamansarov, and I P Baĭkova, and Thanh Tra Nguen, and Do Thi H Thu
September 2009, Molecules (Basel, Switzerland),
O B Kazakova, and I E Smirnova, and E F Khusnutdinova, and O S Zhukova, and L V Fetisova, and G N Apryshko, and N I Medvedeva, and E Iu Iamansarov, and I P Baĭkova, and Thanh Tra Nguen, and Do Thi H Thu
September 2004, European journal of medicinal chemistry,
O B Kazakova, and I E Smirnova, and E F Khusnutdinova, and O S Zhukova, and L V Fetisova, and G N Apryshko, and N I Medvedeva, and E Iu Iamansarov, and I P Baĭkova, and Thanh Tra Nguen, and Do Thi H Thu
April 2015, Chinese journal of natural medicines,
O B Kazakova, and I E Smirnova, and E F Khusnutdinova, and O S Zhukova, and L V Fetisova, and G N Apryshko, and N I Medvedeva, and E Iu Iamansarov, and I P Baĭkova, and Thanh Tra Nguen, and Do Thi H Thu
January 2020, Chemistry & biodiversity,
O B Kazakova, and I E Smirnova, and E F Khusnutdinova, and O S Zhukova, and L V Fetisova, and G N Apryshko, and N I Medvedeva, and E Iu Iamansarov, and I P Baĭkova, and Thanh Tra Nguen, and Do Thi H Thu
April 2017, Natural products and bioprospecting,
O B Kazakova, and I E Smirnova, and E F Khusnutdinova, and O S Zhukova, and L V Fetisova, and G N Apryshko, and N I Medvedeva, and E Iu Iamansarov, and I P Baĭkova, and Thanh Tra Nguen, and Do Thi H Thu
June 2006, Journal of enzyme inhibition and medicinal chemistry,
O B Kazakova, and I E Smirnova, and E F Khusnutdinova, and O S Zhukova, and L V Fetisova, and G N Apryshko, and N I Medvedeva, and E Iu Iamansarov, and I P Baĭkova, and Thanh Tra Nguen, and Do Thi H Thu
November 2011, Archiv der Pharmazie,
Copied contents to your clipboard!